Extracellular DNA filaments associated with surface polysaccharide II give Clostridioides difficile biofilm matrix a network-like structure [0.03%]
与表面多糖II相关联的胞外DNA丝赋予艰难梭菌生物被膜基质网状结构
Tania Kamwouo,Sylvie Bouttier,Séverine Domenichini et al.
Tania Kamwouo et al.
Clostridioides difficile is an anaerobic, spore-forming, Gram-positive bacterium, and a leading cause of healthcare-associated intestinal infections. Recurrences occur frequently, most of them being relapses. Apart from spores, C. difficile...
Receptor-targeted Lactococcus lactis mitigate Clostridioides difficile infection [0.03%]
靶向受体的乳酸菌可减轻难辨梭菌感染
Yue Zhang,Wei Sun,Hao Wu et al.
Yue Zhang et al.
Engineered bacteria play an important role in colorectal disease. Lactococcus lactis (L. lactis) can inhibit Clostridioides difficile (C. difficile) by producing antimicrobial peptide nisin. However, its insufficient nisin production levels...
Development of a toxin-selective immunotracer for in vivo detection of Clostridioides difficile infection by immunoPET [0.03%]
一种用于体内检测难辨梭菌感染的毒株特异性免疫示踪剂的开发免疫PET）
Mario González-Arjona,Lorena Cussó,Luis Alcalá et al.
Mario González-Arjona et al.
Background: Clostridioides difficile infection (CDI) is a major healthcare challenge that is associated with high morbidity and mortality. Current diagnostic methods are limited in terms of specificity and invasiveness, n...
Guiding Clostridioides difficile Infection Prevention Efforts in a Hospital Setting With AI [0.03%]
利用人工智能指导医院环境中艰难梭菌感染的预防工作
Shengpu Tang,Stephanie Shepard,Rebekah Clark et al.
Shengpu Tang et al.
Importance: Increasingly, artificial intelligence (AI) is being used to develop models that can identify patients at high risk for adverse outcomes. However, the clinical impact of these models remains largely unrealized....
Methods of a Reproducible Mouse Model of Clostridioides difficile Infection to Investigate Novel Bacterial-Based Therapies [0.03%]
建立 reproducible 的难辨梭菌感染小鼠模型的方法及其在调查新型细菌疗法中的应用研究
Katya Douchant,Jill Greenlaw,Prameet M Sheth
Katya Douchant
Mice are widely used in science and have played an instrumental role in understanding immune mechanisms, testing cancer therapies, and serving as model systems to better understand physiological processess. Mouse models have also been widel...
Clostridioides difficile-related reactive arthritis: A scoping review of the literature [0.03%]
由难辨梭菌相关反应性关节炎：文献综述
Dimitrios Deligeorgakis,Makri Evangelia,Konstantinos Tsafis et al.
Dimitrios Deligeorgakis et al.
Reactive arthritis (ReA) is an inflammatory arthritis triggered by preceding infection. While various bacterial pathogens are well-established as causative agents, the role of Clostridioides difficile remains less elucidated. Α scoping rev...
Lefika Bathobakae,Rammy Bashir,Atang Koodirile et al.
Lefika Bathobakae et al.
Clostridioides difficile enteritis (CDE) is a rare but clinically significant form of Clostridioides difficile infection (CDI) affecting the small intestine. CDE poses a diagnostic challenge owing to its rarity, complexity, and nonspecific ...
Unique growth and morphology properties of Clade 5 Clostridioides difficile strains revealed by single-cell time-lapse microscopy [0.03%]
单细胞延时显微镜揭示难辨梭菌第五分支的特异生长和形态属性
John W Ribis,César Nieto,Nicholas V DiBenedetto et al.
John W Ribis et al.
Clostridioides difficile is a gastrointestinal pathogen of both humans and agricultural animals and thus a major One Health threat. The C. difficile species consists of five main clades, with Clade 5 currently undergoing speciation from Cla...
In situ identification of toxin-producing Clostridioides difficile in stool samples based on single-cell Raman spectroscopy [0.03%]
基于单细胞拉曼光谱的艰难梭菌产毒株粪便样本原位鉴定研究
Baodian Ling,Fangsheng Wang,Heli Wu et al.
Baodian Ling et al.
Clostridioides difficile (CD) has emerged as one of the most prevalent nosocomial infections in hospitals and is the primary causative agent of antibiotic-associated diarrhea and pseudomembranous colitis. In recent years, C. difficile-induc...
Efficacy and safety of Saccharomyces boulardii as adjunct therapy with Vancomycin in treating Clostridioides difficile infection: A randomized controlled trial [0.03%]
一期和二期艰难梭菌感染的患者在万古霉素治疗基础上联合使用保加利亚乳杆菌作为辅助治疗的有效性和安全性：一项随机对照试验
Taned Chitapanarux,Umaporn Wiracha,Poramed Winichakoon et al.
Taned Chitapanarux et al.
Clostridioides difficile infection (CDI) is a significant cause of hospital-acquired diarrhea, leading to high morbidity, recurrence, and healthcare costs. Probiotics like Saccharomyces boulardii show potential as an adjunct therapy to stan...
Randomized Controlled Trial
Scientific reports. 2025 Jun 2;15(1):19326. DOI:10.1038/s41598-025-04986-2 2025
耗时 0.15216 秒，为您在
48229835
条记录里面共找到 5648 篇文章 [XML]